In 2024 the life sciences sector experienced high levels of cost pressure that drove process transformation in regulatory functions and smarter use of data and human...

Amidst the “burgeoning” interest in developing novel optical imaging drugs and imaging devices to assist various standard surgical procedures, the US Food and Drug A...

As we advance through 2025, biopharma companies are increasingly using artificial intelligence (AI) and new data tools to improve commercial performance and make res...

We are at an important inflection point in our identification and understanding of genetically based diseases, particularly rarer paediatric-onset disorders that imp...

Insights from the Bio-Hermes Trial A New Perspective on Alzheimer's Research Alzheimer's disease (AD) presents a significant challenge, not only for those diagnos...

Q1: Why are highly potent active pharmaceutical ingredients (HPAPIs) playing a transformative role in oncology drug development? A: The rise of precision oncology...

Effective monitoring of medication adherence is vital for the success of any clinical trial. Yet too often archaic, biased methods are used for compliance monitoring...

Over the years, medical device has undergone significant transformation, with the use of evolving technological tools such as artificial intelligence (AI), machine l...

While less resource-intensive than pivotal trials, early phase trials often involve significant scientific uncertainty. Information on a therapy’s side effects, beha...

Biotechs are increasingly driving innovation in research and development. However, this innovation requires specialist support, and it is important to choose the rig...